A Study of Ganetespib in Subjects With ALK-Positive Non-Small-Cell Lung Cancer (NSCLC)

Clinical trial NCT01562015 · COMPLETED

Trial details

NCT number: NCT01562015
Sponsor: Synta Pharmaceuticals Corp.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2012-04-01
Primary completion: 2014-08-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.